Prevalence of Vancomycin-resistant enterococci (VRE) in Egypt (2010–2022): a systematic review and meta-analysis

Journal of the Egyptian Public Health Association

Table 3 Pooled resistance profile of enterococci isolates in Egypt

Group	Included studies	Total number of enterococci	Pooled prevalence(%) and 95% CI	I² Heterogeneity	Heterogeneity test, P value	Publication bias testing
Group	Included studies	Total number of enterococci	Pooled prevalence(%) and 95% CI	I² Heterogeneity	Heterogeneity test, P value	Egger’s test	Begg’s test
Linezolid resistance among VRE	4	89	5.2 (1.3 to 11.5%)	15.81%	P = 0.3126	N/P	N/P
Linezolid resistance among total enterococci isolates	13	927	5.54 (2.33 to 10)	84.82%	P < 0.0001	P = 0.1249	P = 0.1431
Ampicillin resistance among total enterococci isolates	15	1184	65.7 (50.8 to 79.2%)	96.39%	P < 0.0001	P = 0.2124	P = 0.1815
Ampicillin resistance among VRE	4	140	85 (49 to 100%)	95.33%	P < 0.0001	N/P	N/P
HLG resistance among total enterococci isolates	7	565	61.1 47.4 to 73.9%)	90.60%	P < 0.0001	N/P	N/P